Ideaya Biosciences Inc Earnings

Ideaya Biosciences Inc’s revenue jumped 78.43% since last year same period to $7Mn in the Q4 2024. On a quarterly growth basis, Ideaya Biosciences Inc has generated +Inf% jump in its revenue since last 3-months.

Ideaya Biosciences Inc’s net profit fell -283.78% since last year same period to $-130.31Mn in the Q4 2024. On a quarterly growth basis, Ideaya Biosciences Inc has generated -151.47% fall in its net profits since last 3-months.

Ideaya Biosciences Inc’s net profit margin fell -115.08% since last year same period to -1861.6% in the Q4 2024. On a quarterly growth basis, Ideaya Biosciences Inc has generated NaN% jump in its net profit margins since last 3-months.

Ideaya Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.67 - a -8.31% fall from last quarter’s estimates.

Ideaya Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.67.

Ideaya Biosciences Inc’s earning per share (EPS) fell -186.54% since last year same period to -1.49 in the Q4 2024. This indicates that the Ideaya Biosciences Inc has generated -186.54% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Ideaya Biosciences Inc’s return on assets (ROA) stands at -0.23.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Ideaya Biosciences Inc’s return on equity (ROE) stands at -0.33.